Differential apoptosis gene expression in pediatric tumors of the kidney
- 1 February 2000
- journal article
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 35 (2) , 390-395
- https://doi.org/10.1016/s0022-3468(00)90047-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- ApoptosisScience, 1998
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Death Receptors: Signaling and ModulationScience, 1998
- The Receptor for the Cytotoxic Ligand TRAILScience, 1997
- Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53.Journal of Clinical Investigation, 1997
- Signal Transduction by DR3, a Death Domain-Containing Receptor Related to TNFR-1 and CD95Science, 1996
- FLICE, A Novel FADD-Homologous ICE/CED-3–like Protease, Is Recruited to the CD95 (Fas/APO-1) Death-Inducing Signaling ComplexCell, 1996
- Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genesNature, 1996
- Cellular death in neuroblastoma: in situ correlation of apoptosis and bcl‐2 expressionInternational Journal of Cancer, 1995
- Clinical aspects of the rhabdoid tumor of the kidney: A report of the national wilms' tumor study groupMedical and Pediatric Oncology, 1983